Outcomes of chemotherapy-induced nausea and vomiting guideline adherence in pediatric and adult patients: a systematic review-Reference-Cited by-同舟云学术

Outcomes of chemotherapy-induced nausea and vomiting guideline adherence in pediatric and adult patients: a systematic review

Published:2024-06-24 Issue:7 Volume:32 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Renaux Torres Marie Charlotte,Robinson Paula D.,Sung Lillian,Dupuis L. Lee, ,Bate Jessica,Behm Shirley,Bouttefroy Severine,Digout Carol,Kebudi Rejin,Kimball Gwendolyn,Orsey Andrea D.,Phillips Bob,Poirée Marilyne,Tissing Wim,Thompson Joel C.,Thouvenin-Doulet Sandrine,van de Wetering Marianne

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00520-024-08623-y.pdf

Reference37 articles.

1. Aapro M, Caprariu Z, Chilingirov P, Chrapava M, Curca RO, Gales L, Grigorescu AC, Huszno J, Karlinova B, Kellnerova R, Malejcikova M, Marinca M, Petru E, Pluzanski A, Pokorna P, Pribulova Z, Rubach M, Steger GG, Tesarova P, Valekova L, Yordanov N, Walaszkowska-Czyz A (2022) Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea/emesis registry in oncology (NERO). Eur J Cancer 166:126–133

2. Aapro M, Molassiotis A, Dicato M, Pelaez I, Rodriguez-Lescure A, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F, investigators P (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 23: 1986-1992

3. Abunahlah N, Sancar M, Dane F, Ozyavuz MK (2016) Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life. Int J Clin Pharm 38:1464–1476

4. Aseeri M, Mukhtar A, Al Khansa S, Elimam N, Jastaniah W (2013) A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center. J Oncol Pharm Pract 19:138–144

5. Childs DS, Jacobson AC, Mitchell JL, Hubbard JM, Yoon HH, Finnes H, Grothey A, Jatoi A (2017) Prescriber adherence to antiemetic guidelines with the new agent trifuridine-tipiracil. J Community Support Oncol 15:e142–e146